The Journal of Korean Diabetes

Opinion
테크놀로지 혁신이 주도하는 당뇨병 진료환경의 변화: 강신애; J Korean Diabetes. 2024;25(2):57-61.

Diabetes care has experienced great changes due to technological advancements. Recent notable innovations in diabetes technology include real-time continuous glucose monitors, automated insulin delivery systems, insulin patches, and health management...

Statement
1형당뇨병과 2형당뇨병의 혈관합병증, 과연 같을까?: 조윤경; J Korean Diabetes. 2024;25(2):62-68.

Both type 1 and type 2 diabetes can lead to cardiovascular disease (CVD) and high mortality rates. The differing risks and vascular outcomes associated with these two types of diabetes...

Focused Issue
GLP-1수용체작용제: 정승민; J Korean Diabetes. 2024;25(2):69-75.

Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted by food intake from L cells of the ileum. GLP-1 contributes to blood glucose control through three main mechanisms: promoting glucose-dependent insulin...

Focused Issue
GLP-1/GIP수용체작용제: Tirzepatide의 작용기전을 중심으로: 오태정; J Korean Diabetes. 2024;25(2):76-81.

Tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, has demonstrated remarkable effectiveness in lowering glucose levels and reducing weight in the SURPASS and SURMOUNT...

Focused Issue
글루카곤 수용체작용제의 기전 및 GLP-1/글루카곤/GIP수용체 삼중 효현제의 효과: 민세희; J Korean Diabetes. 2024;25(2):82-88.

With an increasing prevalence of diabetes and its complications, there is a need for new therapies to improve glycemic control and weight management. Multireceptor agonists may be a means to...

Information Desk
2024 1형당뇨병 환자 지원을 위한 정책 개정: 유재현; J Korean Diabetes. 2024;25(2):89-92.

Type 1 diabetes mellitus is a condition where the pancreas beta cells are destroyed due to autoimmune mechanisms or viral infections, resulting in the inability to produce insulin. The Korean...

Information Desk
비대면 당뇨병 영양교육: 이정숙; J Korean Diabetes. 2024;25(2):93-98.

Non-face-to-face education has rapidly increased and become common due to the development of information and communication technology and mobile devices to help respond to COVID-19. Non-face-to-face education is conducted using...

Information Desk
사회생태학적 관점으로 바라본 당뇨병을 갖고 있는 청년의 삶: 박유정; J Korean Diabetes. 2024;25(2):99-106.

Young people with diabetes in Korea face a healthcare transition from adolescence to adulthood, involving various management tasks. Imagine a patient who is struggling to stay on track with their...

Original Article
2023 대국민 당뇨병 인식 조사 결과: 유빈, 임성철, 구미현, 대한당뇨병학회 언론-홍보위원회; J Korean Diabetes. 2024;25(2):107-116.

Background: According to the Diabetes Fact Sheet published by the Korean Diabetes Association, as of 2020, one in six adults (16.7%) over the age of 30 were diagnosed with diabetes....

Current Issue: Volume 25(2); Jun 2024

Opinion

테크놀로지 혁신이 주도하는 당뇨병 진료환경의 변화: 강신애; J Korean Diabetes. 2024;25(2):57-61. Published online June 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.2.57

Statement

1형당뇨병과 2형당뇨병의 혈관합병증, 과연 같을까?: 조윤경; J Korean Diabetes. 2024;25(2):62-68. Published online June 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.2.62

Focused Issues

GLP-1수용체작용제: 정승민; J Korean Diabetes. 2024;25(2):69-75. Published online June 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.2.69

GLP-1/GIP수용체작용제: Tirzepatide의 작용기전을 중심으로: 오태정; J Korean Diabetes. 2024;25(2):76-81. Published online June 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.2.76

글루카곤 수용체작용제의 기전 및 GLP-1/글루카곤/GIP수용체 삼중 효현제의 효과: 민세희; J Korean Diabetes. 2024;25(2):82-88. Published online June 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.2.82

Information Desks

2024 1형당뇨병 환자 지원을 위한 정책 개정: 유재현; J Korean Diabetes. 2024;25(2):89-92. Published online June 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.2.89

비대면 당뇨병 영양교육: 이정숙; J Korean Diabetes. 2024;25(2):93-98. Published online June 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.2.93

사회생태학적 관점으로 바라본 당뇨병을 갖고 있는 청년의 삶: 박유정; J Korean Diabetes. 2024;25(2):99-106. Published online June 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.2.99

Original Article

2023 대국민 당뇨병 인식 조사 결과: 유빈, 임성철, 구미현, 대한당뇨병학회 언론-홍보위원회; J Korean Diabetes. 2024;25(2):107-116. Published online June 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.2.107

Volume 25, No. 2

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

MOST VIEWED

5,023	Clinical Nutrition Therapy for Weight Control in Obese Diabetic Patients
4,489	Revisiting the Diabetes Crisis in Korea: Call for Urgent Action
6,163	Use of Dual-Energy X-ray Absorptiometry for Body Composition in Chronic Disease Management
2,129	Guidelines for the Use of 2023 Food Exchange Lists for Diabetes Meal Planning
5,896	Recent Advances in Anti-Obesity Drugs

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2024 by Korean Diabetes Association. All rights reserved.

prev

next